 Chundo Oh
Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 13 | 2020 | 216 | 2.200 |
Why?
| | SOX9 Transcription Factor | 7 | 2016 | 15 | 2.010 |
Why?
| | Mitogen-Activated Protein Kinases | 13 | 2003 | 29 | 0.920 |
Why?
| | Protein Kinase C | 13 | 2003 | 55 | 0.920 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 351 | 0.750 |
Why?
| | Cell Differentiation | 8 | 2016 | 174 | 0.660 |
Why?
| | Cells, Cultured | 15 | 2020 | 802 | 0.640 |
Why?
| | Connective Tissue Growth Factor | 1 | 2016 | 1 | 0.630 |
Why?
| | Growth Plate | 1 | 2016 | 29 | 0.610 |
Why?
| | rho-Associated Kinases | 1 | 2016 | 6 | 0.610 |
Why?
| | Pyridines | 2 | 2016 | 50 | 0.610 |
Why?
| | Collagen Type II | 4 | 2016 | 36 | 0.600 |
Why?
| | Amides | 1 | 2016 | 21 | 0.600 |
Why?
| | Extracellular Matrix Proteins | 2 | 2014 | 176 | 0.600 |
Why?
| | Animals | 25 | 2020 | 5312 | 0.580 |
Why?
| | Signal Transduction | 13 | 2020 | 588 | 0.560 |
Why?
| | Chondrogenesis | 5 | 2003 | 30 | 0.550 |
Why?
| | Isoenzymes | 8 | 2002 | 63 | 0.500 |
Why?
| | Mesoderm | 8 | 2003 | 21 | 0.490 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 28 | 0.430 |
Why?
| | Cartilage, Articular | 5 | 2020 | 586 | 0.410 |
Why?
| | Genome | 1 | 2010 | 15 | 0.400 |
Why?
| | Apoptosis | 5 | 2003 | 292 | 0.400 |
Why?
| | Binding Sites | 3 | 2016 | 93 | 0.390 |
Why?
| | Mice, Knockout | 5 | 2020 | 399 | 0.380 |
Why?
| | Rats | 4 | 2016 | 966 | 0.370 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 7 | 2003 | 18 | 0.330 |
Why?
| | Intervertebral Disc Degeneration | 2 | 2022 | 117 | 0.320 |
Why?
| | Cartilage | 6 | 2010 | 168 | 0.300 |
Why?
| | Enzyme Inhibitors | 8 | 2016 | 160 | 0.300 |
Why?
| | Mice | 9 | 2020 | 1894 | 0.300 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 11 | 2003 | 23 | 0.270 |
Why?
| | Osteoarthritis | 2 | 2020 | 369 | 0.260 |
Why?
| | Nitric Oxide | 5 | 2003 | 107 | 0.260 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2003 | 60 | 0.240 |
Why?
| | Intervertebral Disc | 2 | 2016 | 243 | 0.240 |
Why?
| | Chick Embryo | 8 | 2003 | 22 | 0.240 |
Why?
| | Enzyme Activation | 9 | 2003 | 140 | 0.240 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 8 | 2003 | 38 | 0.230 |
Why?
| | Caspases | 5 | 2003 | 32 | 0.230 |
Why?
| | Awards and Prizes | 1 | 2022 | 24 | 0.230 |
Why?
| | Macrophages | 2 | 1999 | 129 | 0.220 |
Why?
| | Gene Expression Profiling | 2 | 2014 | 183 | 0.220 |
Why?
| | Sirolimus | 1 | 2001 | 20 | 0.220 |
Why?
| | Malocclusion | 1 | 2020 | 1 | 0.210 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2020 | 3 | 0.210 |
Why?
| | Intervertebral Disc Displacement | 1 | 2022 | 121 | 0.210 |
Why?
| | Low Back Pain | 1 | 2022 | 133 | 0.200 |
Why?
| | Receptors, Vitronectin | 1 | 2000 | 5 | 0.200 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 163 | 0.200 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2020 | 13 | 0.200 |
Why?
| | Metformin | 1 | 2020 | 21 | 0.200 |
Why?
| | Receptors, Laminin | 1 | 1999 | 2 | 0.200 |
Why?
| | Enhancer Elements, Genetic | 2 | 2016 | 10 | 0.190 |
Why?
| | Menisci, Tibial | 2 | 2020 | 166 | 0.180 |
Why?
| | Up-Regulation | 1 | 2020 | 220 | 0.180 |
Why?
| | Cell Proliferation | 2 | 2016 | 232 | 0.170 |
Why?
| | Base Sequence | 2 | 2016 | 166 | 0.170 |
Why?
| | Gene Expression | 2 | 2017 | 272 | 0.160 |
Why?
| | Receptors, CCR5 | 1 | 2017 | 29 | 0.160 |
Why?
| | Introns | 1 | 2016 | 18 | 0.160 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2017 | 38 | 0.160 |
Why?
| | Sternum | 1 | 2016 | 5 | 0.160 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2016 | 12 | 0.160 |
Why?
| | Gene Deletion | 1 | 2016 | 57 | 0.150 |
Why?
| | Extremities | 1 | 2016 | 30 | 0.150 |
Why?
| | Cell Movement | 1 | 2017 | 119 | 0.150 |
Why?
| | Cell Line, Transformed | 1 | 2016 | 21 | 0.150 |
Why?
| | Osteoblasts | 1 | 2016 | 62 | 0.150 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 108 | 0.150 |
Why?
| | Interleukin-1 | 2 | 2014 | 91 | 0.150 |
Why?
| | Osteogenesis | 1 | 2016 | 94 | 0.150 |
Why?
| | Protein Binding | 2 | 2014 | 155 | 0.150 |
Why?
| | RNA, Messenger | 1 | 2016 | 371 | 0.140 |
Why?
| | Cadherins | 4 | 2003 | 38 | 0.140 |
Why?
| | Position-Specific Scoring Matrices | 1 | 2014 | 1 | 0.140 |
Why?
| | Nucleotide Motifs | 1 | 2014 | 2 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2014 | 27 | 0.140 |
Why?
| | Protein Transport | 1 | 2014 | 42 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 494 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2014 | 42 | 0.140 |
Why?
| | Trans-Activators | 3 | 2003 | 30 | 0.130 |
Why?
| | MicroRNAs | 1 | 2014 | 63 | 0.130 |
Why?
| | Cell Line | 3 | 2010 | 360 | 0.130 |
Why?
| | Blotting, Western | 3 | 2003 | 225 | 0.120 |
Why?
| | Down-Regulation | 4 | 2016 | 134 | 0.120 |
Why?
| | Cell Division | 3 | 2001 | 122 | 0.120 |
Why?
| | Caspase 3 | 5 | 2003 | 29 | 0.120 |
Why?
| | Inflammation | 1 | 2014 | 360 | 0.110 |
Why?
| | Protein Kinase C-alpha | 5 | 2002 | 7 | 0.110 |
Why?
| | Fibronectins | 3 | 2000 | 31 | 0.110 |
Why?
| | Cell Adhesion | 3 | 2000 | 51 | 0.110 |
Why?
| | Limb Buds | 2 | 2009 | 2 | 0.110 |
Why?
| | Humans | 9 | 2022 | 31481 | 0.110 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2010 | 5 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 512 | 0.100 |
Why?
| | Transcriptional Activation | 1 | 2010 | 30 | 0.100 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2000 | 34 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 74 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2010 | 38 | 0.100 |
Why?
| | Rabbits | 4 | 2003 | 326 | 0.100 |
Why?
| | Integrins | 2 | 2000 | 27 | 0.100 |
Why?
| | Body Patterning | 1 | 2009 | 3 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 70 | 0.090 |
Why?
| | Cytoskeletal Proteins | 3 | 2003 | 34 | 0.090 |
Why?
| | Bone and Bones | 1 | 2009 | 110 | 0.090 |
Why?
| | Phosphorylation | 3 | 2001 | 199 | 0.080 |
Why?
| | Collagen | 3 | 2003 | 111 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2020 | 832 | 0.080 |
Why?
| | Matrix Metalloproteinase 13 | 2 | 2017 | 36 | 0.080 |
Why?
| | Immunohistochemistry | 2 | 2014 | 494 | 0.080 |
Why?
| | Disease Progression | 2 | 2020 | 861 | 0.070 |
Why?
| | Flavonoids | 5 | 2003 | 18 | 0.070 |
Why?
| | Tretinoin | 1 | 2003 | 19 | 0.060 |
Why?
| | Protein Kinases | 1 | 2003 | 16 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2003 | 50 | 0.060 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1999 | 42 | 0.060 |
Why?
| | NF-kappa B | 1 | 2003 | 112 | 0.060 |
Why?
| | Cell Adhesion Molecules | 2 | 2000 | 45 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2017 | 308 | 0.060 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2001 | 2 | 0.060 |
Why?
| | Cell Culture Techniques | 1 | 2001 | 52 | 0.050 |
Why?
| | Carbazoles | 1 | 2000 | 6 | 0.050 |
Why?
| | Facial Pain | 1 | 2020 | 7 | 0.050 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 10 | 0.050 |
Why?
| | Nociception | 1 | 2020 | 9 | 0.050 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2001 | 91 | 0.050 |
Why?
| | Sulfonamides | 1 | 2000 | 64 | 0.050 |
Why?
| | Mice, Obese | 1 | 2020 | 8 | 0.050 |
Why?
| | Cell Fractionation | 1 | 2000 | 6 | 0.050 |
Why?
| | Epidermal Growth Factor | 1 | 2000 | 33 | 0.050 |
Why?
| | Integrin alpha6beta1 | 1 | 1999 | 1 | 0.050 |
Why?
| | Laminin | 1 | 1999 | 10 | 0.050 |
Why?
| | Protein Kinase C-delta | 1 | 1999 | 13 | 0.050 |
Why?
| | Random Allocation | 1 | 2020 | 164 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 76 | 0.050 |
Why?
| | Receptors, Muscarinic | 1 | 1999 | 6 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 580 | 0.040 |
Why?
| | Time Factors | 2 | 2001 | 1902 | 0.040 |
Why?
| | Proteoglycans | 2 | 2014 | 419 | 0.040 |
Why?
| | beta Catenin | 3 | 2003 | 46 | 0.040 |
Why?
| | Nitroprusside | 3 | 2002 | 8 | 0.040 |
Why?
| | SOXD Transcription Factors | 1 | 2016 | 1 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2017 | 71 | 0.040 |
Why?
| | Child | 1 | 2022 | 1572 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2016 | 125 | 0.040 |
Why?
| | Aggrecans | 1 | 2017 | 200 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2009 | 46 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 469 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 1273 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 290 | 0.040 |
Why?
| | Cytokines | 1 | 2017 | 364 | 0.030 |
Why?
| | Risk Factors | 1 | 2022 | 2664 | 0.030 |
Why?
| | Transfection | 1 | 2014 | 154 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2014 | 92 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2014 | 248 | 0.030 |
Why?
| | Cattle | 1 | 2014 | 260 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2014 | 95 | 0.030 |
Why?
| | Homeostasis | 1 | 2014 | 110 | 0.030 |
Why?
| | alpha Catenin | 2 | 2003 | 2 | 0.030 |
Why?
| | Nitric Oxide Donors | 2 | 2002 | 7 | 0.030 |
Why?
| | Phenotype | 2 | 2002 | 379 | 0.030 |
Why?
| | Caspase Inhibitors | 2 | 2001 | 6 | 0.030 |
Why?
| | Dimerization | 1 | 2010 | 21 | 0.030 |
Why?
| | Chromatin | 1 | 2010 | 22 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 82 | 0.030 |
Why?
| | DNA | 1 | 2010 | 139 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 295 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 19 | 0.020 |
Why?
| | Mutation | 1 | 2010 | 464 | 0.020 |
Why?
| | Male | 1 | 2022 | 17583 | 0.020 |
Why?
| | Cytochalasin D | 1 | 2003 | 6 | 0.020 |
Why?
| | Female | 1 | 2022 | 18253 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2002 | 12 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2002 | 32 | 0.020 |
Why?
| | Hydrolysis | 1 | 2002 | 16 | 0.010 |
Why?
| | DNA Primers | 1 | 2002 | 64 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2001 | 29 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 254 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2001 | 40 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 217 | 0.010 |
Why?
| | Embryonic Induction | 1 | 2000 | 1 | 0.010 |
Why?
| | Receptors, Fibronectin | 1 | 2000 | 1 | 0.010 |
Why?
| | Imidazoles | 1 | 2001 | 74 | 0.010 |
Why?
| | Isoquinolines | 1 | 2000 | 16 | 0.010 |
Why?
| | Pyrroles | 1 | 2000 | 22 | 0.010 |
Why?
| | Indoles | 1 | 2000 | 58 | 0.010 |
Why?
| | Bucladesine | 1 | 1999 | 3 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 7 | 0.010 |
Why?
| | HL-60 Cells | 1 | 1999 | 14 | 0.010 |
Why?
| | Receptor, Muscarinic M3 | 1 | 1999 | 2 | 0.010 |
Why?
| | Carbachol | 1 | 1999 | 5 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1999 | 6 | 0.010 |
Why?
| | Protein Kinase C-epsilon | 1 | 1999 | 2 | 0.010 |
Why?
| | Models, Biological | 1 | 2001 | 428 | 0.010 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 23 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 155 | 0.010 |
Why?
| | Culture Techniques | 1 | 1998 | 38 | 0.010 |
Why?
|
|
Oh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|